J.W. Cole Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3M Buy
12,617
+1,890
+18% +$393K 0.05% 362
2026
Q1
$2.27M Sell
10,727
-990
-8% -$213K 0.08% 225
2025
Q4
$2.23M Buy
11,717
+344
+3% +$64.7K 0.05% 356
2025
Q3
$1.79M Buy
11,373
+2,348
+26% +$363K 0.03% 503
2025
Q2
$1.52M Buy
9,025
+1,078
+14% +$160K 0.03% 520
2025
Q1
$1.09M Buy
+7,947
New +$1.01M 0.03% 511
2024
Q3
Sell
-2,332
Closed -$229K 936
2024
Q2
$229K Sell
2,332
-4,025
-63% -$410K 0.01% 795
2024
Q1
$712K Buy
6,357
+247
+4% +$26.6K 0.04% 424
2023
Q4
$616K Buy
+6,110
New +$606K 0.04% 428
2023
Q3
Sell
-2,214
Closed -$209K 744
2023
Q2
$209K Buy
+2,214
New +$187K 0.01% 696

Other funds holding CAH

J.W. Cole Advisors's CAH Position: Q2 2026 in Review

J.W. Cole Advisors increased its Cardinal Health (CAH) stake by 18% in Q2 2026, buying an estimated $393K and bringing the position to 12,617 shares worth $3M. The position accounts for 0.05% of the portfolio, ranked #362.

J.W. Cole Advisors first reported a position in CAH in Q2 2023 and has held it in 10 quarters since. 417 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • J.W. Cole Advisors held 12,617 shares of Cardinal Health worth $3M as of Q2 2026.
  • J.W. Cole Advisors bought 1,890 Cardinal Health shares in Q2 2026, an estimated $393K.
  • Cardinal Health made up 0.05% of J.W. Cole Advisors's portfolio in Q2 2026, its #362 holding.
  • J.W. Cole Advisors first reported a position in Cardinal Health in Q2 2023 and has held it in 10 quarters since.
  • 417 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.